首页
学术期刊
论文检测
AIGC检测
热点
更多
数据
Entinostat/pembrolizumabLack of efficacy: case report
被引:0
作者
:
机构
:
来源
:
Reactions Weekly
|
2023年
/ 1938卷
/ 1期
关键词
:
D O I
:
10.1007/s40278-023-30736-9
中图分类号
:
学科分类号
:
摘要
:
引用
收藏
页码:595 / 595
相关论文
共 50 条
[31]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2025,
2040
(1)
:821
-821
[32]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2023,
1944
(1)
:474
-474
[33]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2023,
1948
(1)
:358
-358
[34]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2023,
1975
(1)
:307
-307
[35]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2024,
2022
(1)
:232
-232
[36]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2022,
1921
(1)
:240
-240
[37]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2024,
2037
(1)
:352
-352
[38]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2025,
2060
(1)
:315
-315
[39]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2024,
2032
(1)
:382
-382
[40]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2022,
1911
(1)
:343
-343
←
1
2
3
4
5
→
共 50 条
[31]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2025,
2040
(1)
:821
-821
[32]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2023,
1944
(1)
:474
-474
[33]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2023,
1948
(1)
:358
-358
[34]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2023,
1975
(1)
:307
-307
[35]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2024,
2022
(1)
:232
-232
[36]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2022,
1921
(1)
:240
-240
[37]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2024,
2037
(1)
:352
-352
[38]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2025,
2060
(1)
:315
-315
[39]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2024,
2032
(1)
:382
-382
[40]
PembrolizumabLack of efficacy: case report
[J].
Reactions Weekly,
2022,
1911
(1)
:343
-343
←
1
2
3
4
5
→